Vivian de Jong

PHD Candidate - OIO

Contact

Recent publications

Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial Vivian de Jong, Willy Theel, Manuel Castro Cabezas, Diederick Grobbee, Wouter Jukema, Stella Trompet
JHEP Reports, 2025, vol. 7

Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment Willy B Theel, Vivian D de Jong, Manuel Castro Cabezas, Diederick E Grobbee, Johan W Jukema, Stella Trompet
European Journal of Clinical Investigation, 2024, vol. 55

A global survey of health care workers' awareness of non-alcoholic fatty liver disease Stan Driessen, Vivian D de Jong, Koen C van Son, Tatiana Klompenhouwer, Yann Colardelle, Marco Alings, Cristophe Moreno, Stefan D Anker, Manuel Castro Cabezas, Adriaan G Holleboom, Diederick E Grobbee, Maarten E Tushuizen
United European Gastroenterology Journal, 2023, vol. 11, p.654-662

Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, Maarten E Tushuizen, Adriaan G Holleboom, Jean-Claude Tardif, A Michael Lincoff, Gregory G Schwartz, Manuel Castro Cabezas, Diederick E Grobbee
PLoS ONE, 2022, vol. 17, p.1-12